Research Article

Rosiglitazone Protects against Acetaminophen-Induced Acute Liver Injury by Inhibiting Multiple Endoplasmic Reticulum Stress Pathways

Figure 5

Rosiglitazone pretreatment suppressed APAP-induced activation of the hepatic IRE-XBP1-JNK pathway. (a) Representative immunoblots of hepatic p-IRE (upper panel) and IRE (lower panel). (b) Densitometry of p-IRE showing upregulation by APAP and reversal by RSG pretreatment. (c) Representative immunoblots of hepatic p-JNK (upper panel) and JNK (lower panel). (d) Densitometry of p-JNK showing upregulation by APAP and reversal by RSG pretreatment. (e) Representative immunoblots of hepatic XBP1 (upper panel) and LaminA/C (lower panel) as the gel loading control. (f) Densitometry of XBP1 showing upregulation by APAP and reversal by RSF pretreatment. All data are expressed as (). and compared to the control group (0 time point), ¶  and ¶¶  compared to the APAP group at the same time point.
(a)
(b)
(c)
(d)
(e)
(f)